Canada's Valeant Pharmaceuticals International Inc said it offered to purchase Botox maker Allergan Inc to boost its skin and eye-care portfolio. Valeant said it had offered to pay $48.30 per share in cash and 0.83 of its common share for each Allergan share.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 6.03% or $8.08/share to $142.00. In the past year, the shares have traded as low as $81.33 and as high as $142.00. On average, 3082430 shares of AGN exchange hands on a given day and today's volume is recorded at 10995132.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 3.24% or $3.96/share to $126.01. In the past year, the shares have traded as low as $71.99 and as high as $153.10. On average, 1992590 shares of VRX exchange hands on a given day and today's volume is recorded at 2948031.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 3.21% or $4.31/share to $138.76. In the past year, the shares have traded as low as $72.59 and as high as $170.45. On average, 372348 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 318584.
Source
